Cabaletta Bio (CABA) Amortizatization of Intangibles (2020 - 2025)
Cabaletta Bio (CABA) posted quarterly Amortizatization of Intangibles of $890000.0 for Q4 2025, up 11.81% year-over-year from $796000.0 in Q4 2024, and up 150.0% quarter-over-quarter from $356000.0 in Q3 2025.
Powered by 
Analysis
Cabaletta Bio (CABA) Amortizatization of Intangibles (2020 - 2025) Analysis & Trends
Cabaletta Bio's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $890000.0 for Q4 2025.
- In Q4 2025, Amortizatization of Intangibles rose 11.81% year-over-year to $890000.0; the TTM figure through Dec 2025 stood at $1.6 million (up 1.77% YoY), while the FY2025 annual figure was $1.6 million, up 1.77% from the prior year.
- Amortizatization of Intangibles for Q4 2025 stood at $890000.0, up from $356000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $890000.0 in Q4 2025, with the low at -$431000.0 in Q4 2023.
- The 5-year median for Amortizatization of Intangibles is $132000.0 (2022), against an average of $202888.9.
- The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles slumped 1036.96% in 2023, then jumped 4646.15% in 2024.
- Cabaletta Bio's Amortizatization of Intangibles stood at -$12000.0 in 2021, then soared by 483.33% to $46000.0 in 2022, then plunged by 1036.96% to -$431000.0 in 2023, then soared by 284.69% to $796000.0 in 2024, then gained by 11.81% to $890000.0 in 2025.
- Business Quant data shows CABA's Amortizatization of Intangibles at $890000.0 in Q4 2025, $356000.0 in Q3 2025, and $142000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Cabaletta Bio | 522.26 Mn | 522.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 890,000.00 |
| Sep 30, 2025 | 356,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Mar 31, 2025 | 167,000.00 |
| Dec 31, 2024 | 98,000.00 |
| Sep 30, 2024 | 261,000.00 |
| Jun 30, 2024 | 552,000.00 |
| Mar 31, 2024 | 617,000.00 |
| Dec 31, 2023 | 383,000.00 |
| Sep 30, 2023 | 641,000.00 |
| Jun 30, 2023 | 94,000.00 |
| Mar 31, 2023 | 104,000.00 |
| Dec 31, 2022 | 508,000.00 |
| Sep 30, 2022 | 55,000.00 |
| Jun 30, 2022 | 74,000.00 |
| Mar 31, 2022 | 48,000.00 |
| Sep 30, 2021 | -12,000.00 |
| Jun 30, 2021 | -21,000.00 |
| Mar 31, 2021 | -29,000.00 |
| Dec 31, 2020 | -38,000.00 |